drugset / Trial / NCT03108937

Effects of Dexmedetomidine on Breast Cancer Cell Function in Vitro

NCT03108937 ↗

Completed 24 enrolled RenJi Hospital
RandomizedParallel-groupDouble-blindTreatment

Summary

Dexmedetomidine is widely used as an anaesthetic for general anesthesia during surgery. Previous studies in cells and animals show that dexmedetomidine may promote cancer growth. Using serum from breast cancer surgery patients randomized to receive dexmedetomidine or saline during surgery, we investigated the effects of dexmedetomidine on proliferation, migration and metastasis in MCF-7 breast cancer cells in vitro.

Timeline

Start
2017-04-12
Primary completion
2017-07-07
Completion
2017-09-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 0.5 ug/kg —